Hepatitis C virus RNA and antibody response in the clinical course of acute hepatitis C virus infection.

Department of Infectious Diseases, University of Brescia, Italy.
Hepatology (Impact Factor: 11.19). 11/1992; 16(4):877-81.
Source: PubMed

ABSTRACT Hepatitis C virus RNA, anti-hepatitis C virus immune response and biochemical markers of liver injury were investigated in 17 patients with acute non-A, non-B hepatitis. At the first observation, 1 to 3 wk from the clinical onset, all patients had hepatitis C virus RNA in their serum, and most (15 of 17) were positive for second-generation anti-hepatitis C virus enzyme immunoassay. Follow-up serum samples were available for 10 patients. The rate of recombinant immunoblot assay-confirmed anti-hepatitis C virus enzyme immunoassay reactivities increased from 67% in the first 3 wk to 86% after 21 wk. Elevated ALT levels were associated with hepatitis C virus RNA positivity in most of cases, but the viral nucleic acid was also detected in sera with normal or slightly increased enzyme values. None of the single antibodies tested were related to hepatitis C virus RNA positivity or to the clinical phase of the infection. Therefore hepatitis C virus RNA determination might provide important additional information as compared with anti-hepatitis C virus markers, allowing earlier diagnosis, discrimination of active infection and, possibly, prognostic evaluation.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Hepatitis C virus (HCV) infection is a relatively common disease. There are some 150 million chronic HCV-infected subjects throughout the world. The natural history of HCV disease is characterized by a period of primary infection followed by a period of chronic infection, usually associated with a liver disease, which may develop cirrhosis, hepatic failure and hepatocellular carcinoma. During the primary phase, there is usually an acute hepatitis, only icteric in a minority of cases (20%). Fulminant hepatic failure is rare. In most patients (80%), primary HCV infection becomes chronic. The course of chronic hepatitis C is usually slow but varies according to subjects, because there is no cytopathopatic effect of HCV and the tissular abnormalities are mediated by the host immune response. The level of serum alanine aminotransferase (ALT) allows us to distinguish two patterns of chronic hepatitis C: chronic hepatitis with normal or elevated ALT. In the former type, the liver disease is slowly progressive with no or low risk of cirrhosis, and a good long-term prognosis. In contrast, in the latter type, 20–30% of patients may develop cirrhosis within 10–20 years, and 4–8% die from liver-related causes. However, serum ALT levels are not a good prognosis factor on an individual basis. Only liver histology may classify chronic hepatitis, estimate the rate of progression towards cirrhosis and define the prognosis. Several cofactors play an important role and may accelerate the development of cirrhosis: older age at infection, male gender, coinfection with Hepatitis B virus and immunodepression (transplantation, HIV infection, etc). In patients with cirrhosis, the incidence of hepatocellular carcinoma is about 3% (1,5–5%) per year.
    Médecine et Maladies Infectieuses 03/2000; 30. DOI:10.1016/S0399-077X(00)88855-1 · 0.91 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Recurrent hepatitis C infection after orthotopic liver transplantation (OLT) is frequent and may occur as early as a few weeks postoperatively. Early histopathological features of recurrent hepatitis C virus (HCV) infection may be modified by immunosuppressive therapy and can be difficult to differentiate from acute allograft rejection (AAR). Thus, we retrospectively compared histopathological features of liver biopsy specimens from two carefully selected patient groups: one with unequivocal recurrent hepatitis C, the other with unequivocal AAR. Index biopsy specimens obtained at the time of the appearance of liver test abnormalities after OLT and all serial liver biopsy specimens (2 to 13 per patient) were assessed under code and scored semiquantitatively for 44 histopathological variables. The index biopsy specimens from patients with recurrent HCV infection and AAR index biopsies (AAR-Ib) differed significantly (P < .05) for 11 features (10 features were statistically associated with AAR and 1 with early recurrence of HCV infection). Statistically significant features associated with AAR included bile duct injury with overlapping nuclei, lymphocytic infiltrates and necrosis, endothelialitis, portal inflammatory infiltrates containing eosinophils and polymorphonuclear leukocytes, hepatocyte mitoses, and zone 3 canalicular cholestasis. In contrast, the only statistically significant feature associated with early recurrent HCV was sinusoidal dilatation. Stepwise discriminant analysis showed that the presence of eosinophils in the portal inflammatory infiltrate, bile duct necrosis, and bile duct lymphocytic infiltrates were independently associated with AAR. However, serial biopsy specimens from patients with recurrent HCV infection showed statistically significant progression in scores for portal inflammation, portal lymphoid aggregates, and lobular inflammation. We conclude that (1) multiple histopathological features are associated with AAR; (2) early recurrent HCV infection is characterized by elevated alanine aminotransferase levels, positive HCV RNA by polymerase chain reaction (PCR), and absence of diagnostic histopathological features; and (3) serial biopsies are needed to demonstrate progression of histopathological features of recurrent hepatitis C. (Liver Transpl Surg 1997 Jul;3(4):398-406)
    Liver Transplantation 07/1997; 3(4):398-406. DOI:10.1053/jlts.1997.v3.pm0009346770 · 3.79 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A mathematical model for HCV infection is established, in which the effect of dendritic cells (DC) and cytotoxic T lymphocytes (CTL) on HCV infection is considered. The basic reproduction numbers of chronic HCV infection and immune control are found. The obtained results show that the infection dies out finally as the basic reproduction number of HCV infection is less than unity, and the infection becomes chronic as it is greater than unity. In the presence of chronic infection, the existence of immune control equilibrium is discussed completely, which illustrates that the backward bifurcation may occur under certain conditions, and that the two quantities, the sizes of the activated DC and the removed CTL during their average life-terms, play a critical role in controlling chronic HCV infection and immune response. The occurrence of backward bifurcation implies that there may be bistability for the model, i.e., the outcome of infection depends on the initial situation. By choosing the activated rate of non-activated DC or the cross-representation rate of activated DC as bifurcation number, Hopf bifurcation for certain condition shows the existence of periodic solution of the model. Again, numerical simulations suggest the dynamical complexity of the model including the instability of immune control equilibrium and the existence of stable periodic solution.
    Journal of Theoretical Biology 01/2015; 365. DOI:10.1016/j.jtbi.2014.10.039 · 2.30 Impact Factor